The tissue inhibitor of metalloproteinases-1 improves migration and adhesion of hematopoietic stem and progenitor cells

Experimental Hematology

Volumn 41, Issue 9, 2013, Pages 823-831.e2

  Wilk, C Matthias ^a   Schildberg, Frank A ^b,c   Lauterbach, Marcel A ^d,e   Cadeddu, Ron Patrick ^a   Fröbel, Julia ^a   Westphal, Volker ^e   Tolba, René H ^c   Hell, Stefan W ^e   Czibere, Akos ^a   Bruns, Ingmar ^a   Haas, Rainer ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d CNRS   (France)

^e MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BETA1 INTEGRIN; CASPASE 3; CD34 ANTIGEN; CD63 ANTIGEN; FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE; STROMAL CELL DERIVED FACTOR 1ALPHA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VERY LATE ACTIVATION ANTIGEN 4; VERY LATE ACTIVATION ANTIGEN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING KINETICS; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL ADHESION; CELL HOMING; CELL MIGRATION; CELL PROTECTION; CELL STIMULATION; CELL SURFACE; COMPLEX FORMATION; CONTROLLED STUDY; ENGRAFTMENT; EX VIVO STUDY; GENE SILENCING; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR BINDING; WNT SIGNALING PATHWAY;

MURINAE;

EID: 84883555864     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2013.04.010     Document Type: Article

References (35)

1. Gomez D.E., Alonso D.F., Yoshiji H., Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur J Cell Biol 1997, 74:111-122.
2. Chirco R., Liu X.W., Jung K.K., Kim H.R. Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev 2006, 25:99-113.
3. Rossi L., Ergen A.V., Goodell M.A. TIMP-1 deficiency subverts cell-cycle dynamics in murine long-term HSCs. Blood 2011, 117:6479-6488.
4. Jung K.K., Liu X.W., Chirco R., Fridman R., Kim H.R. Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. EMBO J 2006, 25:3934-3942.
5. Liu X.W., Bernardo M.M., Fridman R., Kim H.R. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway. J Biol Chem 2003, 278:40364-40372.
6. Dasse E., Bridoux L., Baranek T., et al. Tissue inhibitor of metalloproteinase-1 promotes hematopoietic differentiation via caspase-3 upstream the MEKK1/MEK6/p38alpha pathway. Leukemia 2007, 21:595-603.
7. Egea V., Zahler S., Rieth N., et al. Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates mesenchymal stem cells through let-7f microRNA and Wnt/beta-catenin signaling. Proc Natl Acad Sci U S A 2012, 109:E309-E316.
8. + hematopoietic stem cells. Blood 2002, 99:2037-2044.
9. Hell S.W., Wichmann J. Breaking the diffraction resolution limit by stimulated emission: stimulated-emission-depletion fluorescence microscopy. Opt Lett 1994, 19:780-782.
10. Westphal V., Lauterbach M.A., Di Nicola A., Hell S.W. Dynamic far-field fluorescence nanoscopy. New J Phys 2007, 9:435.
11. Luque A., Gomez M., Puzon W., Takada Y., Sanchez-Madrid F., Cabanas C. Activated conformations of very late activation integrins detected bya group of antibodies (HUTS) specific for a novel regulatory region (355-425) of the common beta 1 chain. J Biol Chem 1996, 271:11067-11075.
12. Aiuti A., Webb I.J., Bleul C., Springer T., Gutierrez-Ramos J.C. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997, 185:111-120.
13. Simmons P.J., Masinovsky B., Longenecker B.M., Berenson R., Torok-Storb B., Gallatin W.M. Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood 1992, 80:388-395.
14. Krutzik P.O., Nolan G.P. Intracellular phospho-protein staining techniques for flow cytometry: Monitoring single cell signaling events. Cytometry A 2003, 55:61-70.
15. Janzen V., Forkert R., Fleming H.E., et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 2006, 443:421-426.
16. Katayama Y., Hidalgo A., Furie B.C., Vestweber D., Furie B., Frenette P.S. PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: Evidence for cooperation between E-selectin ligands and alpha4 integrin. Blood 2003, 102:2060-2067.
17. Sanchez-Aparicio P., Dominguez-Jimenez C., Garcia-Pardo A. Activation of the alpha 4 beta 1 integrin through the beta 1 subunit induces recognition of the RGDS sequence in fibronectin. J Cell Biol 1994, 126:271-279.
18. Kovach N.L., Lin N., Yednock T., Harlan J.M., Broudy V.C. Stem cell factor modulates avidity of alpha 4 beta 1 and alpha 5 beta 1 integrins expressed on hematopoietic cell lines. Blood 1995, 85:159-167.
19. Papayannopoulou T., Priestley G.V., Nakamoto B., Zafiropoulos V., Scott L.M. Molecular pathways in bone marrow homing: dominant role of alpha(4)beta(1) over beta(2)-integrins and selectins. Blood 2001, 98:2403-2411.
20. + cells on vascular endothelium under shear flow. J Clin Invest 1999, 104:1199-1211.
21. Potocnik A.J., Brakebusch C., Fassler R. Fetal and adult hematopoietic stem cells require beta1 integrin function for colonizing fetal liver, spleen, and bone marrow. Immunity 2000, 12:653-663.
22. Papayannopoulou T., Priestley G.V., Nakamoto B., Zafiropoulos V., Scott L.M., Harlan J.M. Synergistic mobilization of hemopoietic progenitor cells using concurrent beta1 and beta2 integrin blockade or beta2-deficient mice. Blood 2001, 97:1282-1288.
23. Guedez L., Stetler-Stevenson W.G., Wolff L., et al. Invitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest 1998, 102:2002-2010.
24. Bertaux B., Hornebeck W., Eisen A.Z., Dubertret L. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. JInvest Dermatol 1991, 97:679-685.
25. Hayakawa T., Yamashita K., Tanzawa K., Uchijima E., Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 1992, 298:29-32.
26. Guedez L., Mansoor A., Birkedal-Hansen B., et al. Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis. Blood 2001, 97:1796-1802.
27. Chesler L., Golde D.W., Bersch N., Johnson M.D. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. Blood 1995, 86:4506-4515.
28. Guedez L., McMarlin A.J., Kingma D.W., Bennett T.A., Stetler-Stevenson M., Stetler-Stevenson W.G. Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis. Am J Pathol 2001, 158:1207-1215.
29. Wagers A.J., Allsopp R.C., Weissman I.L. Changes in integrin expression are associated with altered homing properties of Lin(-/lo)Thy1.1(lo)Sca-1(+)c-kit(+) hematopoietic stem cells following mobilization by cyclophosphamide/granulocyte colony-stimulating factor. Exp Hematol 2002, 30:176-185.
30. Haviernik P., Diaz M.T., Haviernikova E., Tse W., Stetler-Stevenson W.G., Bunting K.D. Hematopoiesis in mice is extremely resilient to wide variation in TIMP/MMP balance. Blood Cells Mol Dis 2008, 41:179-187.
31. Docherty A.J., Lyons A., Smith B.J., et al. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985, 318:66-69.
32. Stetler-Stevenson W.G. Tissue inhibitors of metalloproteinases in cell signaling: Metalloproteinase-independent biological activities. Sci Signal 2008, 1:re6.
33. Nakajima H., Ito M., Smookler D.S., et al. TIMP-3 recruits quiescent hematopoietic stem cells into active cell cycle and expands multipotent progenitor pool. Blood 2010, 116:4474-4482.
34. Shen Y., Winkler I.G., Barbier V., Sims N.A., Hendy J., Levesque J.P. Tissue inhibitor of metalloproteinase-3 (TIMP-3) regulates hematopoiesis and bone formation invivo. PLoS One 2010, 5.
35. Qi J.H., Ebrahem Q., Moore N., et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 2003, 9:407-415.